Search dm+d | This VMP cannot be matched against our prescribing data.
Name | Ganciclovir 500mg powder for solution for infusion vials |
BNF code | 0503022D0AAAAAA |
Virtual Therapeutic Moiety | Ganciclovir |
Date identifier became valid | 17 Feb 2023 |
Previous product identifier | 324781006 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 19 Jan 2009 |
Previous name | Ganciclovir 500mg powder for solution for injection vials |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | vial |
Unit dose unit of measure | vial |
Virtual Product Ingredient | |
---|---|
Ingredient | Ganciclovir sodium |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 372848001 |
Strength value numerator | 500.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | solutioninfusion.intravenous |
Dose Form | |
Formulation | Powder for solution for infusion |
Drug Route | |
Route | Intravenous |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Cymevene 500mg powder for concentrate for solution for infusion vials (Neon Healthcare Ltd) | |
Ganciclovir 500mg powder for concentrate for solution for infusion vials (Kensington Pharma Ltd) | |
Ganciclovir 500mg powder for concentrate for solution for infusion vials (Reig Jofre UK Ltd) | |
Virtual Medicinal Product Packs | |
Ganciclovir 500mg powder for solution for infusion vials 5 vial |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.